Company intelligence / Profile preview

Pattern Bioscience

Austin, Texas, United Statespattern.bio ↗

Ownership: Private
Employees: ~51
Development stage: Preclinical

Overview

Pattern Bioscience is developing a next-generation clinical microbiology diagnostic platform that rapidly identifies pathogens and determines their antibiotic susceptibility directly from patient samples, bypassing traditional culture steps. The technology has demonstrated the ability to deliver more comprehensive and reliable diagnoses days faster than current standards. The company is in the development stage with no commercialized products yet but has received significant investment and industry recognition for its disruptive potential.

Therapeutic areas: Infectious Diseases
Modalities: DeviceDiagnostic platform (phenotypic single-cell analysis)
Industry: Pathology

Partnerships

CARB-X funding partnership for rapid ID/AST development

Beyond the preview

Go deeper on Pattern Bioscience.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pattern Bioscience.

Explore the full profile